Number of the records: 1
Quinazoline compounds
- 1.
SYSNO ASEP 0534505 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title Quinazoline compounds Author(s) Baszczyňski, Ondřej (UOCHB-X) RID, ORCID
Dejmek, Milan (UOCHB-X) RID, ORCID
Hu, Y. E. (US)
Jansa, Petr (UOCHB-X) RID
Lansdon, E. (US)
Mackman, R. (US)
Šimon, Petr (UOCHB-X) ORCIDYear of issue 2019 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. US10206926 Date of the patent acceptance 19.02.2019 Name of the patent owner Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i Code of the issuer name US001 - United States Patent and Trademark Office (USPTO) Alexandria Current use B - Patent je využíván na základě uzavřené licenční smlouvy mezi vlastníkem a uživatelem Language eng - English Keywords quinazoline ; reverse transcriptase ; antiviral ; NNRTI Subject RIV CC - Organic Chemistry OECD category Organic chemistry Institutional support UOCHB-X - RVO:61388963 Annotation Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds. Workplace Institute of Organic Chemistry and Biochemistry Contact asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418 Year of Publishing 2021 Electronic address https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=10206926B2&KC=B2&FT=D&ND=4&date=20190219&DB=&locale=en_EP
Number of the records: 1